Mesoblast Limited; Non-healing Bones Repaired In Clinical Trial Using Adult Stem Cells  
8/6/2008 11:27:48 AM

Melbourne, Aug 6, 2008 (ABN Newswire) - The Royal Melbourne Hospital and Australia's regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), today jointly announced successful results from the long bone fracture repair clinical trial using Mesoblast's proprietary adult stem cell technology.